Analysts Conflicted on These Healthcare Names: Biohaven Ltd. (BHVN), Olema Pharmaceuticals (OLMA) and Hims & Hers Health (HIMS)
at www.tipranks.com (Thu, 19-Feb 7:10 AM)
Olema Oncology Secures $218.5 Million from Oversubscribed Public Offering—What Does This Mean for Their Breast Cancer Drug Pipeline?
Market Chameleon (Fri, 21-Nov 8:34 AM)
Olema Oncology Raises $190 Million in Public Offering—What Could This Mean for the Company’s Clinical Pipeline?
Market Chameleon (Thu, 20-Nov 10:33 AM)
